Profound Medical Corp.

TSX:PRN Stock Report

Market Cap: CA$271.8m

Profound Medical Management

Management criteria checks 3/4

Profound Medical's CEO is Arun Menawat, appointed in Aug 2016, has a tenure of 8.25 years. total yearly compensation is $889.95K, comprised of 41.6% salary and 58.4% bonuses, including company stock and options. directly owns 2.2% of the company’s shares, worth CA$5.99M. The average tenure of the management team and the board of directors is 1.8 years and 3.7 years respectively.

Key information

Arun Menawat

Chief executive officer

US$889.9k

Total compensation

CEO salary percentage41.6%
CEO tenure8.3yrs
CEO ownership2.2%
Management average tenure1.8yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

Does Profound Medical (TSE:PRN) Have A Healthy Balance Sheet?

May 03
Does Profound Medical (TSE:PRN) Have A Healthy Balance Sheet?

Is Profound Medical (TSE:PRN) Using Debt In A Risky Way?

Sep 15
Is Profound Medical (TSE:PRN) Using Debt In A Risky Way?

Will Profound Medical (TSE:PRN) Spend Its Cash Wisely?

Sep 07
Will Profound Medical (TSE:PRN) Spend Its Cash Wisely?

Here's Why We're Not Too Worried About Profound Medical's (TSE:PRN) Cash Burn Situation

Jan 07
Here's Why We're Not Too Worried About Profound Medical's (TSE:PRN) Cash Burn Situation

We Think Profound Medical (TSE:PRN) Can Easily Afford To Drive Business Growth

Jul 02
We Think Profound Medical (TSE:PRN) Can Easily Afford To Drive Business Growth

We Take A Look At Why Profound Medical Corp.'s (TSE:PRN) CEO Compensation Is Well Earned

May 13
We Take A Look At Why Profound Medical Corp.'s (TSE:PRN) CEO Compensation Is Well Earned

CEO Compensation Analysis

How has Arun Menawat's remuneration changed compared to Profound Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$31m

Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$28m

Dec 31 2023US$890kUS$370k

-US$29m

Sep 30 2023n/an/a

-US$29m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$27m

Dec 31 2022US$916kUS$344k

-US$29m

Sep 30 2022n/an/a

-US$29m

Jun 30 2022n/an/a

-US$30m

Mar 31 2022n/an/a

-US$31m

Dec 31 2021US$4mUS$481k

-US$31m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$2mUS$1m

-US$22m

Sep 30 2020n/an/a

-US$18m

Jun 30 2020n/an/a

-US$17m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$2mUS$531k

-US$15m

Sep 30 2019n/an/a

-US$15m

Jun 30 2019n/an/a

-US$14m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$672kUS$509k

-US$15m

Sep 30 2018n/an/a

-US$16m

Jun 30 2018n/an/a

-US$16m

Mar 31 2018n/an/a

-US$15m

Dec 31 2017US$264kUS$264k

-US$15m

Compensation vs Market: Arun's total compensation ($USD889.95K) is about average for companies of similar size in the Canadian market ($USD726.09K).

Compensation vs Earnings: Arun's compensation has been consistent with company performance over the past year.

CEO

Arun Menawat (69 yo)

8.3yrs

Tenure

US$889,948

Compensation

Dr. Arun Swarup Menawat, Ph D., MBA, serves as an Independent Director of Firefly Neuroscience, Inc. and served as its Chairman. He serves as the Chairman at Profound Medical Corp. Dr. Menawat has been the...

Leadership Team

NamePositionTenureCompensationOwnership
Arun Menawat
Chairman of the Board & CEO8.3yrsUS$889.95k2.2%
CA$ 6.0m
Mathieu Burtnyk
Presidentno dataUS$396.81k0.13%
CA$ 355.4k
Rashed Dewan
Chief Financial Officer3.5yrsUS$669.26k0.19%
CA$ 516.2k
Stephen Kilmer
Investor Relationsno datano datano data
Thomas Tamberrino
Chief Commercial Officerless than a yearno datano data
Matthew Sobczyk
Assistant Corporate Controllerno datano datano data
Levant Tinaz
Software Developerno datano datano data

1.8yrs

Average Tenure

56yo

Average Age

Experienced Management: PRN's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Arun Menawat
Chairman of the Board & CEO9.4yrsUS$889.95k2.2%
CA$ 6.0m
Arthur L. Rosenthal
Independent Director6.4yrsUS$101.96k0.070%
CA$ 190.6k
Brian Ellacott
Independent Lead Director6.4yrsUS$102.91k0.28%
CA$ 749.4k
Cynthia Lavoie
Independent Director3.7yrsUS$97.91k0.024%
CA$ 66.1k
Mark Emberton
Member of Clinical Advisory Boardno datano datano data
Kris Shah
Independent Director2.5yrsUS$96.96kno data
Murielle Lortie
Independent Director4yrsUS$100.41k0.013%
CA$ 34.7k
Laurence Klotz
Member of Clinical Advisory Board2.1yrsno datano data
Adam Kibel
Member of Clinical Advisory Boardno datano datano data
Aytekin Oto
Member of Clinical Advisory Boardno datano datano data
Edward Steiner
Member of Clinical Advisory Board2.1yrsno datano data
Naveen Kella
Member of Clinical Advisory Board2.1yrsno datano data

3.7yrs

Average Tenure

65yo

Average Age

Experienced Board: PRN's board of directors are considered experienced (3.7 years average tenure).